Adebrelimab Combined with Irinotecan Liposomes, 5-FU, CF ± Lenvatinib As First-line Treatment for Advanced ICC
Clinical trial NCT06648525 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06648525
- Sponsor
- Harbin Medical University
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-01
- Primary completion
- 2027-04-01
- Enrollment
- 68
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.